Morgan Stanley’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-113
| Closed | – | – | 7003 |
|
|
2018
Q3 | $0 | Sell |
113
-24
| -18% | – | ﹤0.01% | 7026 |
|
|
2018
Q2 | $0 | Sell |
137
-65
| -32% | – | ﹤0.01% | 6979 |
|
|
2018
Q1 | $0 | Hold |
202
| – | – | ﹤0.01% | 6913 |
|
|
2017
Q4 | $0 | Sell |
202
-50
| -20% | – | ﹤0.01% | 6898 |
|
|
2017
Q3 | $0 | Hold |
252
| – | – | ﹤0.01% | 6826 |
|
|
2017
Q2 | $0 | Sell |
252
-62
| -20% | – | ﹤0.01% | 6834 |
|
|
2017
Q1 | $1K | Buy |
314
+55
| +21% | +$175 | ﹤0.01% | 6548 |
|
|
2016
Q4 | $0 | Sell |
259
-126
| -33% | – | ﹤0.01% | 6727 |
|
|
2016
Q3 | $1K | Sell |
385
-27
| -7% | -$70 | ﹤0.01% | 6485 |
|
|
2016
Q2 | $4K | Hold |
412
| – | – | ﹤0.01% | 6285 |
|
|
2016
Q1 | $5K | Hold |
412
| – | – | ﹤0.01% | 6298 |
|
|
2015
Q4 | $6K | Hold |
412
| – | – | ﹤0.01% | 6360 |
|
|
2015
Q3 | $6K | Hold |
412
| – | – | ﹤0.01% | 6366 |
|
|
2015
Q2 | $8K | Sell |
412
-50
| -11% | -$971 | ﹤0.01% | 6356 |
|
|
2015
Q1 | $9K | Sell |
462
-63
| -12% | -$1.23K | ﹤0.01% | 6254 |
|
|
2014
Q4 | $16K | Sell |
525
-115
| -18% | -$3.51K | ﹤0.01% | 6119 |
|
|
2014
Q3 | $23K | Sell |
640
-3,086
| -83% | -$111K | ﹤0.01% | 5972 |
|
|
2014
Q2 | $166K | Buy |
3,726
+2,713
| +268% | +$121K | ﹤0.01% | 5248 |
|
|
2014
Q1 | $49K | Sell |
1,013
-471
| -32% | -$22.8K | ﹤0.01% | 5726 |
|
|
2013
Q4 | $55K | Buy |
1,484
+799
| +117% | +$29.6K | ﹤0.01% | 5563 |
|
|
2013
Q3 | $70K | Sell |
685
-994
| -59% | -$102K | ﹤0.01% | 5157 |
|
|
2013
Q2 | $130K | Buy |
+1,679
| New | +$130K | ﹤0.01% | 5014 |
|